Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance.
Employer will assist with relocation costs.
Internal Number: Booth #7414C
Biogen, in collaboration with MCPHS, offers a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. A fellow gains extensive experiences through various practical activities in both industry and academic settings, which could enhance the potential for accelerated career development.
About Global Medical Writing
Biogen’s Medical Writing Fellowship will focus on clinical and regulatory documents needed for drug development. Over the course of 2 years, the Fellow will work with teams that include physicians, statisticians, clinical pharmacologists, and other scientists to create the documents needed to support the conduct and reporting of clinical trials, as well as the documents needed to obtain and maintain marketing authorization for therapies. Description
In the first year, the Fellow will develop documents at the level of an individual clinical study of a potential new drug. These documents will include the clinical study protocol, which describes how the study will be conducted, and the clinical study report, which documents data results and conclusions of the study. As part of the cross-functional team of scientists and physicians, the Fellow will learn about the purpose, structure, and components of a protocol, and the process required to develop and adapt the protocol during the course of a study.
The Fellow will also become familiar with the interpretation and reporting of the clinical data, the purpose of the clinical study report, and the importance of these data to stakeholders.
Working within cross-functional teams provides exposure to the different scientific and medical functions that contribute to drug development and how they collaborate on clinical studies. Also, developing an understanding of how the study-level documents are created will provide the Fellow with the foundation needed to understand how individual studies support the overall drug development process.
In the second year, the Fellow will work on program-level documents that are required to support all studies within a drug development program, or to support the submission of data to regulatory authorities for marketing authorizations. This will allow the Fellow to gain experience with a wider variety of documents and an understanding of their function within the broader context of drug development.
The fellow will have the opportunity to spend up to 4 months in another department within Biogen. Departments may include, but are not limited to:
To be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit https://mcphs.smapply.io/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.
The MCPHS application portal will open up on October 2, 2023. Applicants must upload the following application materials to the online portal by November 17, 2023:
Letter of intent
Unofficial college transcript
Contact information for three references. References will receive an electronic recommendation form to complete separately.
Incomplete applications WILL NOT be reviewed. Interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
Three recommendation evaluation forms must be submitted no later than November 27, 2023, via the online portal. This is NOT a letter of recommendation but an online form that the reference will need to complete.
Rolling Application Review & Interviews
All submitted applications will be reviewed on a rolling basis. Interviews will also be offered on a rolling basis and opportunities are limited. Priority will be given to those applicants who apply early, well in advance of the deadline.
Rolling interviews will begin mid-October with pre-screens and a mixture of interview rounds, and will conclude in December at the end of the ASHP Midyear Clinical Meeting. Candidates will be notified if selected for an interview.
ASHP Midyear & Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in Las Vegas. Applicants are strongly encouraged to attend. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.
Top candidates may be invited for interviews at the sponsoring company’s location pending COVID – 19 restrictions.
Recognizing that the choice of a Post-Doctoral Industry Fellowship is an important decision, MCPHS in conjunction with the Academic Industry Fellowship Alliance (AIFA), has agreed to extend offers for Fellowships no earlier than December 13, 2023.
Final candidates will be required to go through additional screening / onboarding as required by MCPHS.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide
innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related
therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by
Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today
Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment
for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research
programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders,
movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain.
About MCPHS: MCPHS University provides an academic environment to guide and support fellows toward a successful career
in the biopharmaceutical industry. As a private institution with a history of specializing in the health sciences,
MCPHS University offers programs that embod...y scholarship, professional service, and community outreach.
Through MCPHS University, the fellow will have the opportunity to gain teaching and research experience in an
academic setting. Throughout the program, MCPHS University faculty and company program leaders mentor
fellows according to each fellow’s scholarly and professional interests.